Open access
Nov 2026
Engineered Chiral Probiotics Ameliorate MASH via Gut–Liver Axis
This work establishes a new class of chirality‐enhanced living therapeutics that precisely remodel the gut–liver axis, offering a transformative strategy for treating MASH and its complications.
Jing Chen, Shen Zhang, Yu-Li Zhu et al.
· Advancement of science · 0 citations